-
Terminally ill cancer patients who had end-of life discussions with their physician had better quality of life during their last week and their caregivers had an easier bereavement.
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
-
-
There is promising evidence that botulinum toxin type A provides analgesia in patients with painful focal neuropathy independent of its neuromuscular blocking action.
-
Intravenous thrombolysis is safe and effective for the treatment of ischemic stroke in the time window of 3-4.5 hours after the onset of symptoms.
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
Statins may cause worsening symptoms in patients with myasthenia gravis.
-
Aspirin plus extended-release dipyridamole and clopidogrel are both appropriate options to decrease disability from recurrent stroke; however, telmisartan does not lower risk of suffering a second stroke.
-
Neuromyelitis optica (NMO) may be a unique central nervous system demyelinating disease with distinct clinical and MRI manifestations, as well as different immune and pathological characteristics as compared to multiple sclerosis (MS).